Protalix BioTherapeutics, Inc. (PLX)

Company Overview
Protalix BioTherapeutics, Inc. is a development stage company engaged the development and production of therapeutic protein products. The company's main product, prGCD, is a recombinant Glucocerebrosidase enzyme-based protein which can be used for the treatment of Gaucher Disease. Other products in development include PRX-102, for the treatment of Fabry disease; PRX-111, which is a human fertility hormone; and plant-based acetylcholinestrase, for the use therapeutic and prophylactic indications.

The company doesn't generate any revenue from operations. For the three months ended September 30, 2007, the company incurred net loss of $4.7 million which was 48.2% less than ...

read more


To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 2 Snunit Street, Science Park, Carmiel, 21000, Israel
Mailing Address: -
Phone: 972 4 988 9488
Fax: 972 4 988 9489
Website: http//

Company Details:

Symbol: PLX
SIC: 2836
State location: -
Sector: -
State of Inc: -
Employees: 182
Type: -

Key executives:

Name Age Position